Usage of Dapagliflozin in the management of Type-2 Diabetes Mellitus: A Real world evidence study in Indian patients

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
India, Andhra Pradesh	Hyderabad, Andhra Pradesh, India
India, Andhra Pradesh	Nellor, Andhra Pradesh, India
India, Andhra Pradesh	Vijayawada, Andhra Pradesh, India
India, Chhattisgarh	Raipur, Chhattisgarh, India
India, Delhi	New Delhi, Delhi, India
India, Gujrat	Ahmedabad, Gujrat, India
India, Gujrat	Rajkot, Gujrat, India
India, Gujrat	Surat, Gujrat, India
India, Karnataka	Bangalore, Karnataka, India
India, Maharashtra	Aurangabad, Maharashtra, India
India, Maharashtra	Mumbai, Maharashtra, India
India, Maharashtra	Nagpur, Maharashtra, India
India, Maharashtra	Pune, Maharashtra, India
India, Punjab	Amritsar, Punjab, India
India, Punjab	Bhathinda, Punjab, India
India, Punjab	Chandigarh, Punjab, India
India, Punjab	Ludhiana, Punjab, India
India, Punjab	Patiala, Punjab, India
India, Rajasthan	Jaipur, Rajasthan, India
India, Tamil Nadu	Chennai, Tamil Nadu, India
India, Tamil Nadu	Coimbatore, Tamil Nadu, India
India, Tamil Nadu	Madurai, Tamil Nadu, India
India, Tamil Nadu	Pudhucherry, Tamil Nadu, India
India, Tamil Nadu	Salem, Tamil Nadu, India
India, Telangana	Hyderabad, Telangana, India
India, UP	Kanpur, UP, India
India, UP	Lucknow, UP, India
India, West Bengal	Jalpaiguri, West Bengal, India
India, West Bengal	Kolkata, West Bengal, India